German Oncology Center

The Linac-Pet Scan Opco Ltd (Legal name) belongs to the broader group of the German Oncology Center (Business name, GOC), which provide their services in general as an oncology center. GOC was founded by a world-renowned group of oncologists with significant prior experience at oncology centers and clinics in Germany. The group has a strong record in both basic and clinical research, focusing on the translation of research results into innovative diagnostic and therapeutic services relating to all aspects oncology. Moreover, the GOC has established important collaborations with both local hospitals and hospitals in Europe and Middle-East, and it aspires to become an important referral center for cancer patients from all neighbouring countries. Additionally, the Centre is committed to being regularly involved in research projects, conferences and other research activities that will ensure that its staff of medical professional remains constantly updated and involved with internationally innovative clinical research. In parallel, the GOC pursues and advances its academic educational and research programs. There is an agreed cooperation with the Technical University of Cyprus through the Cancer Research Center. GOC is the academic training center for the Medical Program of the European University of Cyprus. Medical services are organized into five departments: (1) Dept. of Radiation Oncology which offers state-of-the-art external beam radiotherapy and high dose-rate brachytherapy treatments. (2) Dept. of Nuclear Medicine that offers PET/CT imaging and a long range of radionuclide therapy options. (3) Dept. of Diagnostic and Interventional Radiology which is one of the most up-to-date and well equipped in Cyprus. (4) Dept. of Medical Oncology where chemotherapy, targeted therapies, hormonal manipulation and other treatments are offered. (5) Dept. of Medical Physics and Engineering which participates in the development of new image processing techniques serving the image guided treatment of malignant disease in every anatomical site.

Role of institution in the project

WP7

Participation and contribution to: (i) the formation of the final open call(s) for data incorporation from external partners, (ii) nominated experts committee, (iii) evaluation committee.

Participation and contribution in the: (i) discussions for definition of use cases, (ii) performance and clinical evaluation of use cases. Provision of curated clinical data.

Participation and contribution to the chosen use cases, from the clinical end user and/or researcher perspective.

Participation and contribution to the benchmarking & quality control of data and tool from the clinical end user and/or researcher perspective.

Participation and contribution in the validation and clinical evaluation of the platform.

Dr. Yiannis Roussakis

Dr. Yiannis Roussakis is the Head of Medical Physics (Radiotherapy) and Head of Medical Physics Education and Research program at the German Oncology Center in Cyprus. He holds a BSc in Physics an MSc in Medical Physics, an MSc in ‘Physical Sciences of Imaging in the Biomedical Sciences’ and PhD in Radiotherapy Physics. Upon completion of his academic training, he worked as trainee Medical Physicist in the NHS, UK, and moved to Cyprus in 2017 to join the German Oncology Center. Dr. Roussakis is a member of the Cypriot Association of Medical Physicists, member of the Institute of Physics and Engineering in Medicine, and General Director of the Biomedical Research Foundation, a charity organisation based in Cyprus. Through is current role at GOC, he is and has been acting as the centre’s project lead is several research projects funded through European and National funds. His current research interests lie in the translation of AI/ML applications in clinical practice, including diagnosis, outcome prediction and decision support.

Dr. Konstantinos Zamboglou

Dr. Konstantinos Zamboglou studied medicine in Freiburg, Germany until 2013. In this period, he completed his doctoral thesis at the laboratory of Prof. Aktories with the grade summa cum laude. He was resident in the Department of Radiation Oncology at the University of Freiburg in Germany under the supervision of the renowned oncologist Prof. Grosu. His main area of interest are Interventional Radiotherapy, Translational Oncology and implementation of novel imaging techniques in radiotherapy planning. In 2019 he obtained his board licence and in 2020 his postdoctoral lecture qualification. From 2019-2020 he worked as senior consultant, where he was responsible for the treatment of prostate cancer patients. In 2021 he became also the section head of the department of interventional radiotherapy. He published over 70 research articles in renown and peer-reviewed journals and in 2020 he received the “Herman-Holthusen” Award of the German Society of Radiation Oncology. Since 2021 he is an invited member of the German prostate cancer expert panel and member of the ESTRO-ACROP guideline committee for prostate cancer. Since 2021 he is the deputy medical director at the German Oncology Center in Limassol.

Dr. Konstantinos Ferentinos

Dr. Konstantinos Ferentinos was born in Ioannina Greece, where he studied Medicine. He was awarded the degree in Medicine in 2007. He was resident in the Department of Radiation Oncology at Klinikum Offenbach in Germany under the supervision of the renowned oncologist Prof. Zamboglou. His main area of interest are Interventional Radiotherapy and novel radiation techniques. In 2012 he obtained the PhD in Medicine at the Goethe University Frankfurt. From 2013 to 2015 he worked as consultant at Klinikum Offenbach, where he was responsible for the department of Stereotactic Radiotherapy. In 2016 he worked as senior consultant in the Department of Interventional Radiotherapy at the Iatriko Kentro in Athens. Since 2017 he is the head of the Department of Radiation Oncology at the German Oncology Center in Limassol. He is appointed as Clinical Assistant Professor in Radiation Oncology in the European University of Cyprus, where he teaches final-year medical school students.

Dr. Kristis Vevis

Dr. Kristis Vevis is the Research Project Manager at the German Oncology Center in Limassol, Cyprus. He was awarded a BSc in Biology from the university of Crete, Greece in 2009 and an MSc with distinction in Molecular Medicine from Imperial College London, UK in 2010. He then received a full scholarship for a PhD in Neurobiology which he was awarded from University College London, UK in 2014. In 2014 he moved to Cyprus and started working for Medochemie, a generic pharmaceutical company, in the department of Process validation which he was finally managing. In 2020 he worked for 6 months as Scientific advisor and Regulatory affairs manager in Kassandra Trading Ltd. He then started at his current position in German Oncology Center and at the same time he graduated from Cyprus International Institute of Management where he was awarded with Master in Business Administration (MBA).

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Find out more

Attend the Open Call Webinar

We’re hosting a webinar with more details on how to apply to the Open Call on April 26 from 10:00 – 11:30 CEST

SIGN UP

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

Sign up for more information

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.

Participate